Pharmastar Blog News and Events

2017-2018 Flu Shot Recommendations

Posted by Luke Johnson on Sep 22, 2017 12:14:46 PM

The single best way to protect against influenza is to get vaccinated. During the 2015-2016 flu season, the estimated number of illnesses prevented by the flu shot was 5.1 million. Also, in April of this year, a study published in Pediatrics was the first of its kind to prove the influenza vaccine reduced the risk of influenza-associated death in children ages six months through 17 years. Influenza is a serious disease and taking measures to prevent it should be a priority.

Read More

Topics: Education, Clinical



Safe Drug and Medical Equipment Use Following a Natural Disaster

Posted by Bob Tanner on Sep 15, 2017 2:18:55 PM

In the wake of Hurricanes Harvey and Irma, the U.S. Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS) are reminding people to take extra precautions when it comes to prescription drugs and medical equipment.

Read More

Topics: Education



First Genetically Engineered Cancer Therapy Approved by FDA

Posted by Luke Johnson on Sep 1, 2017 4:15:36 PM

The federal Food and Drug Administration (FDA) has taken what it describes as “historic action,” approving what it calls the first gene therapy in the United States. It is the first chimeric antigen receptor T cell (CAR-T) therapy to receive FDA approval.

The action offers hope for young patients with a form of acute lymphoblastic leukemia (ALL) just before September, which is Blood Cancer Awareness Month. ALL, a form of blood and bone marrow cancer, is the most common type of cancer in children. As the first immunotherapy based on CAR-T for cancer to be approved, it also offers hope for immune-oncology researchers and pharmaceutical manufacturers.

Read More

Topics: Clinical, Government



What Makes Specialty Drugs Special

Posted by Luke Johnson on Aug 25, 2017 2:45:38 PM

There is no consistent industry definition of “specialty drugs,” but they are usually high-cost, large-molecule biologic products that are often injected to treat genetic conditions or mutations. Specialty drugs frequently target what are referred to as rare diseases and ultra-rare diseases, or orphan and ultra-orphan diseases.

In the United States, a disease is considered rare if it affects less than 200,000 people, and generally if it affects fewer than 10,000 people it is described as “ultra-rare.” There are an estimated 7,000 rare diseases and disorders, affecting a combined total of more than 30 million people in the U.S. This recognition has helped shape the research and development agenda of pharmaceutical manufacturers.
Read More

Topics: Education



Relieving the National Pain of Opioid Abuse

Posted by Luke Johnson on Aug 17, 2017 1:08:46 PM

Opioid addiction is a national epidemic, a crisis so significant that the White House has declared it a national emergency.

Read More

Topics: Education



About Pharmastar

Pharmastar has been focused on providing full-service pharmacy benefits throughout the United States for over 20 years. We administer pharmacy benefits for a wide variety of nation-wide clients including:

  • Commercial plans
  • PACE
  • Medicare Part D
  • Medicaid managed care
Clients are able to take advantage of customized pharmacy network solutions as well as a national network of over 66,000 pharmacies.

Blog Updates